wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35742449-D67325FC-44E2-41CA-8F9F-CB7355C8371B
Q35742449-D67325FC-44E2-41CA-8F9F-CB7355C8371B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35742449-D67325FC-44E2-41CA-8F9F-CB7355C8371B
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.
P2860
Q35742449-D67325FC-44E2-41CA-8F9F-CB7355C8371B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35742449-D67325FC-44E2-41CA-8F9F-CB7355C8371B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83b1edcd35e3b6655b267671ebfb2a6be0ce6521
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.